10-26120695-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_017433.5(MYO3A):c.1796G>T(p.Ser599Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000168 in 1,613,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017433.5 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 30Inheritance: AR, SD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal dominant 90Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO3A | ENST00000642920.2 | c.1796G>T | p.Ser599Ile | missense_variant | Exon 18 of 35 | NM_017433.5 | ENSP00000495965.1 | |||
| MYO3A | ENST00000543632.5 | c.1776+24013G>T | intron_variant | Intron 16 of 16 | 1 | ENSP00000445909.1 | ||||
| MYO3A | ENST00000642197.1 | n.2000G>T | non_coding_transcript_exon_variant | Exon 18 of 27 | ||||||
| MYO3A | ENST00000647478.1 | n.1777-4703G>T | intron_variant | Intron 16 of 29 | ENSP00000493932.1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152108Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.000215 AC: 54AN: 251180 AF XY: 0.000169 show subpopulations
GnomAD4 exome AF: 0.000170 AC: 248AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.000176 AC XY: 128AN XY: 727190 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000151 AC: 23AN: 152108Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 599 of the MYO3A protein (p.Ser599Ile). This variant is present in population databases (rs142289318, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with MYO3A-related conditions. ClinVar contains an entry for this variant (Variation ID: 228978). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MYO3A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The p.Ser599Ile variant in MYO3A has been identified by our laboratory in 2 indi viduals with hearing loss; however, neither individual carried a second variant in the MYO3A gene. It has also been identified in 0.04% (46/126470) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinsti tute.org; dbSNP rs142289318). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Com putational prediction tools and conservation analysis suggest that the variant m ay impact the protein, though this information is not predictive enough to deter mine pathogenicity. In summary, the clinical significance of the p.Ser599Ile var iant is uncertain. ACMG/AMP Criteria applied: PP3. -
Inborn genetic diseases Uncertain:1
The c.1796G>T (p.S599I) alteration is located in exon 18 (coding exon 16) of the MYO3A gene. This alteration results from a G to T substitution at nucleotide position 1796, causing the serine (S) at amino acid position 599 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at